These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15596364)

  • 1. Cloning, expression, purification, and spectroscopic analysis of the fragment 57-102 of human alpha-synuclein.
    Bisaglia M; Trolio A; Tessari I; Bubacco L; Mammi S; Bergantino E
    Protein Expr Purif; 2005 Jan; 39(1):90-6. PubMed ID: 15596364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligopeptide-mediated acceleration of amyloid fibril formation of amyloid beta(Abeta) and alpha-synuclein fragment peptide (NAC).
    Kuroda Y; Maeda Y; Hanaoka H; Miyamoto K; Nakagawa T
    J Pept Sci; 2004 Jan; 10(1):8-17. PubMed ID: 14959887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The aggregation and membrane-binding properties of an alpha-synuclein peptide fragment.
    Madine J; Doig AJ; Middleton DA
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):1127-9. PubMed ID: 15506987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A topological model of the interaction between alpha-synuclein and sodium dodecyl sulfate micelles.
    Bisaglia M; Tessari I; Pinato L; Bellanda M; Giraudo S; Fasano M; Bergantino E; Bubacco L; Mammi S
    Biochemistry; 2005 Jan; 44(1):329-39. PubMed ID: 15628875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural transformation and aggregation of human alpha-synuclein in trifluoroethanol: non-amyloid component sequence is essential and beta-sheet formation is prerequisite to aggregation.
    Li HT; Du HN; Tang L; Hu J; Hu HY
    Biopolymers; 2002 Aug; 64(4):221-6. PubMed ID: 12115139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear localization of alpha-synuclein and its interaction with histones.
    Goers J; Manning-Bog AB; McCormack AL; Millett IS; Doniach S; Di Monte DA; Uversky VN; Fink AL
    Biochemistry; 2003 Jul; 42(28):8465-71. PubMed ID: 12859192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of alpha-synuclein carboxy-terminus on fibril formation in vitro.
    Murray IV; Giasson BI; Quinn SM; Koppaka V; Axelsen PH; Ischiropoulos H; Trojanowski JQ; Lee VM
    Biochemistry; 2003 Jul; 42(28):8530-40. PubMed ID: 12859200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of inhibitor-bound alpha-synuclein dimer: role of alpha-synuclein N-terminal region in dimerization and inhibitor binding.
    Yamaguchi Y; Masuda M; Sasakawa H; Nonaka T; Hanashima S; Hisanaga S; Kato K; Hasegawa M
    J Mol Biol; 2010 Jan; 395(3):445-56. PubMed ID: 19895818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of fibril formation and toxicity of a fragment of alpha-synuclein by an N-methylated peptide analogue.
    Bodles AM; El-Agnaf OM; Greer B; Guthrie DJ; Irvine GB
    Neurosci Lett; 2004 Apr; 359(1-2):89-93. PubMed ID: 15050719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations.
    Dedmon MM; Lindorff-Larsen K; Christodoulou J; Vendruscolo M; Dobson CM
    J Am Chem Soc; 2005 Jan; 127(2):476-7. PubMed ID: 15643843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of copper (II) ion to an Alzheimer's tau peptide as revealed by MALDI-TOF MS, CD, and NMR.
    Ma QF; Li YM; Du JT; Kanazawa K; Nemoto T; Nakanishi H; Zhao YF
    Biopolymers; 2005 Oct; 79(2):74-85. PubMed ID: 15986501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid self-assembly of alpha-synuclein observed by in situ atomic force microscopy.
    Hoyer W; Cherny D; Subramaniam V; Jovin TM
    J Mol Biol; 2004 Jun; 340(1):127-39. PubMed ID: 15184027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases.
    Pawar AP; Dubay KF; Zurdo J; Chiti F; Vendruscolo M; Dobson CM
    J Mol Biol; 2005 Jul; 350(2):379-92. PubMed ID: 15925383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and purification of a recombinant peptide from the Alzheimer's beta-amyloid protein for solid-state NMR.
    Sharpe S; Yau WM; Tycko R
    Protein Expr Purif; 2005 Jul; 42(1):200-10. PubMed ID: 15939307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational properties of the SDS-bound state of alpha-synuclein probed by limited proteolysis: unexpected rigidity of the acidic C-terminal tail.
    de Laureto PP; Tosatto L; Frare E; Marin O; Uversky VN; Fontana A
    Biochemistry; 2006 Sep; 45(38):11523-31. PubMed ID: 16981712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural characterization of the intrinsically unfolded protein beta-synuclein, a natural negative regulator of alpha-synuclein aggregation.
    Bertoncini CW; Rasia RM; Lamberto GR; Binolfi A; Zweckstetter M; Griesinger C; Fernandez CO
    J Mol Biol; 2007 Sep; 372(3):708-22. PubMed ID: 17681539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and topology of the non-amyloid-beta component fragment of human alpha-synuclein bound to micelles: implications for the aggregation process.
    Bisaglia M; Trolio A; Bellanda M; Bergantino E; Bubacco L; Mammi S
    Protein Sci; 2006 Jun; 15(6):1408-16. PubMed ID: 16731975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal migration of human wild-type alpha-synuclein upon gel electrophoresis.
    Moussa CE; Wersinger C; Rusnak M; Tomita Y; Sidhu A
    Neurosci Lett; 2004 Nov; 371(2-3):239-43. PubMed ID: 15519765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein.
    Mishizen-Eberz AJ; Norris EH; Giasson BI; Hodara R; Ischiropoulos H; Lee VM; Trojanowski JQ; Lynch DR
    Biochemistry; 2005 May; 44(21):7818-29. PubMed ID: 15909996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of alpha-synuclein in neurodegenerative diseases.
    Bennett MC
    Pharmacol Ther; 2005 Mar; 105(3):311-31. PubMed ID: 15737408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.